Christopher A. D'Avella, MD
Assistant Professor of Clinical Medicine (Hematology-Oncology)
Faculty Member, Penn Center for Cancer Care Innovation
Co-Director, Cancer Diagnostic Clinic at the Abramson Cancer Center at Penn Presbyterian Medical Center
Department: Medicine
Contact information
Abramson Cancer Center Penn Presbyterian, 51 North 39th Street, Suite 100
Philadelphia, PA 19104
Philadelphia, PA 19104
Education:
BA (Arts in Political Science )
Emory University , 2003.
Pre-Med (Medicine )
Scripps College , 2008.
MD (Medicine )
The George Washington University School of Medicine , 2013.
Permanent linkBA (Arts in Political Science )
Emory University , 2003.
Pre-Med (Medicine )
Scripps College , 2008.
MD (Medicine )
The George Washington University School of Medicine , 2013.
Description of Research Expertise
Christopher D’Avella, MD is an Assistant Professor of Clinical Medicine in the Division of Hematology and Oncology at the Perelman School of Medicine and a faculty member of the Penn Center for Cancer Care Innovation. His clinical practice focuses on thoracic and head and neck malignancies. He has research interests in health care delivery, innovation, and quality improvement. A graduate of the George Washington School of Medicine and Health Sciences, he completed his internal medicine residency at the University of Pittsburgh where he served as chief resident. He subsequently completed his fellowship in Hematology and Oncology at Fox Chase Cancer Center in Philadelphia where he was the chief fellow. He is currently involved in several quality improvement and policy focused projects with the Cancer Service Line for the Abramson Cancer Center. Additionally, he has an interest in financial toxicity and how to improve screening and access to financial counseling services for cancer patients. He also serves as the co medical director for the cancer center’s diagnostic clinic which focuses on improving access to care and time to treatment for newly diagnosed cancer patients.Selected Publications
Meredith Doherty, Kellie Bresz, Kimberly Guglielmo, Christopher Davella, Tamara Cadet, Suzanne Walker, Paul Wileyto: Does financial advocacy improve appointment keeping in patients receiving chemotherapy? ASCO Quality Care Symposium October 2023.Friedes C, Yegya-Raman N, Zhang S, Iocolano M, Cohen RB, Aggarwal C, Thompson JC, Marmarelis ME, Levin WP, Cengel KA, Ciunci CA, Singh AP, D'Avella C, Davis CW, Langer CJ, Feigenberg SJ.: Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression. Clin Lung Cancer Sep 2023.
Aggarwal C, Maity AP, Bauml JM, Long Q, Aleman T, Ciunci C, D'Avella C, Volpe M, Anderson E, Jones LM, Sun L, Singh AP, Marmarelis ME, Cohen RB, Langer CJ, Amaravadi R.: A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer. Oncologist 28: 644-e564, Jul 2023.
Christopher Davella, Erin Mary Bange, Aditi Puri Singh, David W. Dougherty, Peter Edward Gabriel, Rebecca Lawrence Maniago, Jennifer Miao, Colin Harvey, Marcello Ricottone, Lawrence N. Shulman: Clinical pathways innovation: A lesson on the value of clinician based feedback and collaboration with Flatiron Health. ASCO Annual Meeting June 2023.
Yegya-Raman N, Friedes C, Sun L, Iocolano M, Kim KN, Doucette A, Cohen RB, Robinson KW, Levin WP, Cengel KA, Lally B, Agarwal M, D'Avella CA, Marmarelis ME, Kosteva JA, Singh AP, Ciunci CA, Aggarwal C, Berman AT, Langer CJ, Feigenberg SJ.: Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System. Clin Lung Cancer 2023.
Tompkins WP, Hwang WT, Yang YX, Singh A, Ciunci C, D'Avella C, Aggarwal C, Cohen RB, Langer CJ, Mamtani R, Marmarelis ME.: Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens. Clin Lung Cancer 2023.
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, Collin Blakely, Anne Chiang, Thomas A D'Amico, Christopher D'Avella, Afshin Dowlati, Robert J Downey, Martin Edelman, Charles Florsheim, Kathryn A Gold, Jonathan W Goldman, John C Grecula, Christine Hann, Wade Iams, Puneeth Iyengar, Karen Kelly, Maya Khalil, Marianna Koczywas, Robert E Merritt, Nisha Mohindra, Julian Molina, Cesar Moran, Saraswati Pokharel, Sonam Puri, Angel Qin, Chad Rusthoven, Jacob Sands, Rafael Santana-Davila, Michael Shafique, Saiama N Waqar, Kristina M Gregory, Miranda Hughes: Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(12): 1441-1446, Dec 2022.
Sun L, Candelieri-Surette D, Anglin-Foote T, Lynch JA, Maxwell KN, D'Avella C, Singh A, Aakhus E, Cohen RB, Brody RM.: Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 148: 1022-1028, Nov 2022.
Rebecca Maniago, Jennifer Miao, Stephanie Jou; Gregory S. Calip, Shawn Huda, Lawrence N Shulman, Erin Bange, Aditi Singh, Chris D’Avella : Do Clinical Pathways Impede Provider Workflow? A Provider Efficiency Analysis of Time Spent Using an EHR-Embedded Clinical Decision Support Tool. ASCO Quality Symposium Meeting, San Francisco, CA Oct 2022 Notes: "Poster Presentation"
Sara B Hobday, Robert M Brody, Barry Kriegsman, Devraj Basu, Jason Newman, Roger B Cohen, J Nicholas Lukens, Aditi Singh, Christopher A D'Avella, Lova Sun : Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors. JAMA Otolaryngol Head Neck Surg 148(10): 918-926, Aug 2022.